|
|
|
The IMF is pleased to present the most comprehensive coverage of the XIth International Myeloma Workshop.
|
|
|
|
|
P. Leif Bergsagel, MD
Mayo Clinic
Scottsdale, AZ, USA
|
|
|
|
|
Michael Kuehl, MD
National Cancer Institute
Bethesda, MD, USA
|
|
|
|
|
J.D. Shaughnessy Jr., MD
Donna D. and Donald M. Lambert Laboratory for Myeloma Genetics
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, Arkansas, USA
|
|
|
|
|
Rafael Fonseca, MD
Mayo Clinic
Scottsdale, AZ, USA
|
|
|
|
|
Herve Avet-Loiseau, MD
Laboratory of Hematology
University Hospital
Nantes, France
|
|
|
|
|
Brian Van Ness, PhD
Bank On A Cure®
International Myeloma Foundation
|
|
|
|
|
Karin Vanderkerken, MD
Vrije Universiteit Brussel (VUB)
Department Hematology and Immunology
Brussels, Belgium
|
|
|
|
|
Joshua Epstein, MD
Myeloma Institute for Research and Therapy
University of Arkansas for Medical Sciences
Little Rock, Arkansas, USA
|
|
|
|
|
Johannes Drach, MD
Medical University of Vienna
Department of Medicine I
Clinical Division of Oncology
Vienna, Austria
|
|
|
|
|
Shaji Kumar, MD
Mayo Clinic
Hepatology Department
Rochester, MN, USA
|
|
|
back
print
KOS 2007: Molecular Principles Underlying Myeloma 
KOS 2007: Molecular Lesions in Multiple Myeloma 
KOS 2007: Towards a Molecular-Based Risk Stratification of Multiple Myeloma 
KOS 2007: Clinical and Pathological Implications of Myeloma Subtypes 
KOS 2007: Prognostic implications of FISH karyotyping in Myeloma 
KOS 2007: Single Nucleotide Polymorphism Models in Myeloma - From the Bank On A Cure SNP Chip 
KOS 2007: Animal Models of Multiple Myeloma: An Overview 
KOS 2007: The Scid-hu model for Multiple Myeloma 
KOS 2007: Chromosomal and epigenetic abnormalities in MGUS and MM Post-MGUS 
KOS 2007: Microarray Analysis to Predict Response to Thalidomide and the IMIDs 
back to top